Skip to content

Testing session to assess the user experience, usability and safety of the Heroes exergame for stroke patients to train balance

Testing session to assess the user experience, usability and safety of the Heroes exergame for stroke patients to train balance - User experience, usability and safety testing session of Heroes exergame

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56475
Enrollment
10
Registered
2024-01-22
Start date
2023-11-27
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nervous system disorder (chronic stroke) Cerebro Vasculair Accident Stroke

Interventions

None listed

Sponsors

University of Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Having sustained a unilateral stroke in the cerebrum more than 6 months ago. -Experiencing mild to moderate impairments in balance and walking. -Physically able to stand and walk independently without walking aids (e.g. cane). -Aged between 18 and 75 years old.

Exclusion criteria

Exclusion criteria: -Conditions in which physical activity is contra-indicated -Other neurological or musculoskeletal disorder or injuries affecting balance or gait abilities. -Current orthopaedic problems; hip or knee replacement, or limb amputation. -Impaired vision that is not corrected by glasses or lenses. -Current use of psychotropic medication affecting responsiveness, balance or posture. -Behavioural or cognitive problems interfering with compliance to the study protocol. -Unable to use the intervention system independently. -Unable to give personal informed consent

Design outcomes

Primary

MeasureTime frame
The main study parameter is the user experience from the people with stroke.

Secondary

MeasureTime frame
The secondary outcome measures are usability and safety perception from the end-user. This will be assessed with questionnaires and observation of the session.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)